María Isabel Porras-Quesada, PhD student in the Labsinlove team, has received a Fairchild Award at the 21st International Congress on Neutron Capture Therapy (ICNCT-21), held in Buenos Aires, Argentina, from 25 to 30 October 2026. Named after BNCT pioneer Dr. Ralph Fairchild, the award recognises outstanding contributions to the congress by young...
Labsinlove at the UAB Innovation Fair 2026
Labsinlove took part in the UAB Innovation Fair 2026, held on 20 October, the event that connects research from the Universitat Autònoma de Barcelona with companies.
Con sede en el Parque Tecnológico de la Salud de Granada, la empresa busca dos millones de euros para realizar los ensayos clínicos en pacientes con los cánceres de más difícil tratamiento
Investigadores de la UGR · Labsinlove S.L. pone en el mercado compuestos para BNCT, una innovadora terapia para combatir cánceres de mal pronóstico. Solo hay compañías similares en Estados Unidos, Japón, China y Finlandia
The PTS Granada Foundation will host the launch event of the fourth edition of the AcexHealth Accelerator on September 12. This program offers training, support, and mentoring for Andalusian companies and startups in the health sector.
Labsinlove was awarded an R&D incentive from Andalucía TRADE, the Andalusian Government's business development agency, co-financed by the European Union through the European Regional Development Fund (ERDF) (grant 4IIDE2400014). The grant co-funds our R&D programme.
EUIPO has approved a grant to Labsinlove SL which covers partially patenting costs of the company IP.
Neuboron Medtech, Ltd. (Nanjing, China) and Labsinlove, S.L. (Madrid, Spain) have signed a Memorandum of Understanding to collaborate in the development of Boron Neutron Capture Therapy.
LiL is born
Today, Labsinlove S.L. has been registered. It is born from the initiative of a few enthusiastic persons willing to help towards a cure for those cancers of worst prognosis.





